Skip to content

Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension

Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension: a Randomized Crossover Pilot Trial

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05517993
Enrollment
50
Registered
2022-08-26
Start date
2022-09-01
Completion date
2024-12-31
Last updated
2022-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intradialytic Hypotension

Keywords

Intradialytic Hypotension, Chinese herbal medicine, Gui-Lu-Er-Xian-Jiao

Brief summary

Intradialytic hypotension (IDH), a common complication during hemodialysis (HD) could increase patients' morbidity and mortality. Previous studies considered that some Chinese herbal medicine (CHM) plays a complementary role in reducing the frequency of IDH. This trial is aimed to investigate the effect of Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) in patients with intradialytic hypotension.

Interventions

DRUGGui-Lu-Er-Xian-Jiao-Wan

Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) is an ancient CHM formula, mainly originating from processed tortoise shells, antlers, Ginseng, and wolfberry.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* End stage renal disease treated with hemodialysis for ≥3 months * Receive a standard thrice-weekly hemodialysis schedule * More than 25% of hemodialysis sessions complicated by intradialytic hypotension

Exclusion criteria

* Active malignancy * Life-threatening conditions * Pregnancy * Recent participation in another clinical trial for intradialytic hypotension * History of hypersensitivity or contraindication to herbal medicine

Design outcomes

Primary

MeasureTime frameDescription
Intradialytic hypotension episodeEach time of dialysis during 12-weeks study period.Hypotension episode during hemodialysis

Secondary

MeasureTime frameDescription
Early termination of hemodialysisEach time of dialysis during 12-weeks study period.The episode of early termination in hemodialysis due to hypotension
SF-36Baseline, 12 weeks, 28 weeksShort Form (36) Health Survey (SF-36)

Countries

Taiwan

Contacts

Primary ContactChun-Ting Liu
juntin0214@gmail.com+88677317123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026